ADMA生物制品 ADMA
$12.73 −$0.48 (-3.63%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $12.74 +0.08%
开盘$12.88
昨收$13.21
当日区间$12.52 – $13.20
成交量4.65M
市值$2.82B
市盈率（TTM）16.5
股息率–
ADMA 相关新闻
匹配 ADMA Biologics 或代码 ADMA 的头条新闻，按最新排序。
- CCORF Maintains ADMA Biologics(ADMA.US) With Buy Rating, Maintains Target Price $18
- Cantor Fitzgerald Maintains ADMA Biologics(ADMA.US) With Hold Rating, Cuts Target Price to $12 负面
- ADMA Biologics Q2 Adj. EPS $0.16 Misses $0.17 Estimate, Sales $124.395M Miss $131.658M Estimate 负面
- 4: ADMA Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Kestenberg-Messina Kaitlin M.
- Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating, Cuts Target Price to $17 负面
- Raymond James Initiates ADMA Biologics(ADMA.US) With Buy Rating, Announces Target Price $21
- Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating, Cuts Target Price to $20 负面
- CCORF Maintains ADMA Biologics(ADMA.US) With Buy Rating, Maintains Target Price $21
- ADMA Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Kestenberg-Messina Kaitlin M.
- Raymond James Maintains ADMA Biologics(ADMA.US) With Buy Rating, Cuts Target Price to $21 负面
- Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating, Cuts Target Price to $24 负面
- Cantor Fitzgerald Downgrades ADMA Biologics(ADMA.US) to Hold Rating, Maintains Target Price $30 负面
- ADMA Biologics | 4: Statement of changes in beneficial ownership of securities-Director Guiheen Lawrence P.
- ADMA Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Kestenberg-Messina Kaitlin M.
- Cantor Fitzgerald Maintains ADMA Biologics(ADMA.US) With Buy Rating, Maintains Target Price $30
暂无评论——快来第一个聊聊 ADMA。